Etrinabdione for leg pain in peripheral artery disease
Part of Heart & circulation clinical trials.
This study tests an investigational drug called etrinabdione for people with peripheral arterial disease (reduced blood flow to the legs) and type 2 diabetes. The goal is to see if it is safe, tolerable, and might help improve leg pain or walking ability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate or severe leg pain when walking (called claudication) that eases with rest
- You have type 2 diabetes that is reasonably controlled (HbA1c less than 9%)
- If you are taking medication for your condition, it should be stable and working as expected
- You do not plan to have surgery or a stent in your leg within the next year
- You have not had a failed leg procedure in the past 10 days, and you have not had a major amputation of that leg
- You are generally healthy enough to complete the study, can give informed consent, and if you or your partner could become pregnant, you agree to use effective birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized exercise program for people with peripheral arterial disease (PAD), a condition that causes leg pain when walking. The goal is to see if a tailored exercise plan can help reduce pain, improve walking distance, and boost quality of life.
This study tests a new type of exercise that uses a blood-flow restriction cuff to see if it helps people with leg pain from blocked arteries. If you have stable claudication (leg pain when walking) and have been referred to cardiac rehab, you may qualify.
This trial tests a supervised exercise program for people with leg pain when walking caused by narrowed leg arteries. The goal is to see if exercise can improve walking ability and quality of life.
This trial tests whether a drug called diroximel fumarate (Vumerity) can improve blood flow and walking ability in people with peripheral artery disease (PAD). It compares people with PAD to healthy volunteers of the same age.
This study is testing a new drug-coated stent for blocked arteries in the thigh or behind the knee. It may help people with moderate to severe leg pain or wounds by improving blood flow without needing surgery.
This study tests a special balloon coated with medicine to open blocked leg arteries. It may help improve blood flow and reduce pain when walking or at rest.
Hear when a new Peripheral Arterial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.